相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study
Pierre Quartier et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Biologic Switching Among Nonsystemic Juvenile Idiopathic Arthritis Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance Registry
Melissa L. Mannion et al.
JOURNAL OF RHEUMATOLOGY (2021)
Long-Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis Cohort
Mia Glerup et al.
ARTHRITIS CARE & RESEARCH (2020)
Real-World Effectiveness of Common Treatment Strategies for Juvenile Idiopathic Arthritis: Results From a Canadian Cohort
Amieleena Chhabra et al.
ARTHRITIS CARE & RESEARCH (2020)
Outcome Monitoring and Clinical Decision Support in Polyarticular Juvenile Idiopathic Arthritis
Lisa Buckley et al.
JOURNAL OF RHEUMATOLOGY (2020)
Magnetic Resonance Imaging Followup of Temporomandibular Joint Inflammation, Deformation, and Mandibular Growth in Juvenile Idiopathic Arthritis Patients Receiving Systemic Treatment
Andrea Bollhalder et al.
JOURNAL OF RHEUMATOLOGY (2020)
Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis
Esraa M. Eloseily et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Treat-to-target study for improved outcome in polyarticular juvenile idiopathic arthritis
Ariane Klein et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Systemic Treatment for Temporomandibular Joint Arthritis in Juvenile Idiopathic Arthritis
Peter Stoustrup et al.
JOURNAL OF RHEUMATOLOGY (2020)
New Medications Are Needed for Children With Juvenile Idiopathic Arthritis
Hermine I. Brunner et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis
Jessica Tibaldi et al.
RHEUMATOLOGY (2020)
Outcome Measures for Juvenile Idiopathic Arthritis Disease Activity
Chiara Trincianti et al.
ARTHRITIS CARE & RESEARCH (2020)
Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry
Giulia Armaroli et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Successful use of short-term add-on tocilizumab for refractory adult-onset still's disease with macrophage activation syndrome despite treatment with high-dose glucocorticoids, cyclosporine, and etoposide
Shin-Ichiro Ohmura et al.
MODERN RHEUMATOLOGY CASE REPORTS (2020)
Comparative analysis of the etanercept efficacy in children with juvenile idiopathic arthritis under the age of 4 years and children of older age groups using the propensity score matching method
Ekaterina Alexeeva et al.
MODERN RHEUMATOLOGY (2019)
Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up Study
Nienke M. ter Haar et al.
ARTHRITIS & RHEUMATOLOGY (2019)
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis
Sheila T. Angeles-Han et al.
ARTHRITIS & RHEUMATOLOGY (2019)
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis
Sarah Ringold et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Time of Disease-Modifying Antirheumatic Drug Start in Juvenile Idiopathic Arthritis and the Likelihood of a Drug-Free Remission in Young Adulthood
Kirsten Minden et al.
ARTHRITIS CARE & RESEARCH (2019)
Physician practices for withdrawal of medications in inactive systemic juvenile arthritis, Childhood Arthritis and Rheumatology Research Alliance (CARRA) survey
Susan Shenoi et al.
PEDIATRIC RHEUMATOLOGY (2019)
A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis
Cecilia Bava et al.
PEDIATRIC RHEUMATOLOGY (2019)
Emergent high fatality lung disease in systemic juvenile arthritis
Vivian E. Saper et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors
Grant S. Schulert et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis: part 1-results of the Canadian model in the Nordic cohort
Veronika Rypdal et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature
Hafize Emine Sonmez et al.
CLINICAL RHEUMATOLOGY (2018)
Risk Factors for Intraarticular Heterotopic Bone Formation in the Temporomandibular Joint in Juvenile Idiopathic Arthritis
Matthew L. Stoll et al.
JOURNAL OF RHEUMATOLOGY (2018)
Patient characteristics associated with response to NSAID monotherapy in children with systemic juvenile idiopathic arthritis
Anjali Sura et al.
PEDIATRIC RHEUMATOLOGY (2018)
Orofacial symptoms and oral health-related quality of life in juvenile idiopathic arthritis: a two-year prospective observational study
Hanna Rahimi et al.
PEDIATRIC RHEUMATOLOGY (2018)
Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study
Veronika Rypdal et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications
Michael J. Ombrello et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial
Angelo Ravelli et al.
LANCET (2017)
Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans
Yukiko Kimura et al.
PEDIATRIC RHEUMATOLOGY (2017)
Growth and weight gain in children with juvenile idiopathic arthritis: results from the ReACCh-Out cohort
Jaime Guzman et al.
PEDIATRIC RHEUMATOLOGY (2017)
Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic Arthritis
Paula Frid et al.
ARTHRITIS CARE & RESEARCH (2017)
Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review
J. Bradford Rice et al.
CLINICAL THERAPEUTICS (2017)
The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort
Jaime Guzman et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study
Lianne Kearsley-Fleet et al.
RHEUMATOLOGY (2016)
Quantifying the Effect of Temporomandibular Joint Intra-Articular Steroid Injection on Synovial Enhancement in Juvenile Idiopathic Arthritis
Cory M. Resnick et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2016)
A recurring rollercoaster ride: a qualitative study of the emotional experiences of parents of children with juvenile idiopathic arthritis
Oralia Gomez-Ramirez et al.
PEDIATRIC RHEUMATOLOGY (2016)
Parents' information needs and influential factors when making decisions about TNF-α inhibitors
Ellen A. Lipstein et al.
PEDIATRIC RHEUMATOLOGY (2016)
Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration
J. Franova et al.
PEDIATRIC RHEUMATOLOGY (2016)
Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus
Selin Aytac et al.
RHEUMATOLOGY INTERNATIONAL (2016)
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Angelo Ravelli et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab
Gerd Horneff et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Magnetic Resonance Imaging Assessment of Temporomandibular Joint Involvement and Mandibular Growth Following Corticosteroid Injection in Juvenile Idiopathic Arthritis
Nina Lochbuehler et al.
JOURNAL OF RHEUMATOLOGY (2015)
Predictors of response to methotrexate in juvenile idiopathic arthritis
Mohamed Albarouni et al.
PEDIATRIC RHEUMATOLOGY (2014)
Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis Results of a Prospective Cohort Study
Sebastiaan J. Vastert et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis A Multinational, Multicenter Study of 362 Patients
Francesca Minoia et al.
ARTHRITIS & RHEUMATOLOGY (2014)
US Trends in Rates of Arthroplasty for Inflammatory Arthritis Including Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritis
Christina Mertelsmann-Voss et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register
Marieke H. Otten et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis
Flora Mcerlane et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Long-Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis
Daniel J. Lovell et al.
ARTHRITIS AND RHEUMATISM (2013)
2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications
Sarah Ringold et al.
ARTHRITIS AND RHEUMATISM (2013)
I'm the One Taking It: Adolescent Participation in Chronic Disease Treatment Decisions
Ellen A. Lipstein et al.
JOURNAL OF ADOLESCENT HEALTH (2013)
GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength
Jeffrey C. Andrews et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register
Janneke Anink et al.
RHEUMATOLOGY (2013)
A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
Nicolino Ruperto et al.
ARTHRITIS AND RHEUMATISM (2012)
Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
Nicolino Ruperto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
Fabrizio De Benedetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis
Esi Morgan Dewitt et al.
ARTHRITIS CARE & RESEARCH (2012)
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
Pierre Quartier et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial
Pirjo Tynjala et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Heterotopic Ossification of the Temporomandibular Joint in Juvenile Idiopathic Arthritis
Sarah Ringold et al.
JOURNAL OF RHEUMATOLOGY (2011)
American College of Rheumatology Provisional Criteria for Defining Clinical Inactive Disease in Select Categories of Juvenile Idiopathic Arthritis
Carol A. Wallace et al.
ARTHRITIS CARE & RESEARCH (2011)
2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features
Timothy Beukelman et al.
ARTHRITIS CARE & RESEARCH (2011)
AGREE II: advancing guideline development, reporting and evaluation in health care
Melissa C. Brouwers et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)
Effectiveness of Leflunomide in Patients with Juvenile Idiopathic Arthritis in Clinical Practice
Ivan Foeldvari et al.
JOURNAL OF RHEUMATOLOGY (2010)
Development and Validation of a Composite Disease Activity Score for Juvenile Idiopathic Arthritis
Alessandro Consolaro et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study
Norman Ilowite et al.
CLINICAL RHEUMATOLOGY (2009)
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
Shumpei Yokota et al.
LANCET (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Factors Influencing the efficacy of intra-articular steroid injections in patients with juvenile idiopathic arthritis
Peter Marti et al.
EUROPEAN JOURNAL OF PEDIATRICS (2008)
Low-dose methotrexate treatment for oligoarticular juvenile idiopathic arthritis nonresponsive to intra-articular corticosteroids
R Brik et al.
CLINICAL RHEUMATOLOGY (2005)
Patterns of clinical remission in select categories of juvenile idiopathic arthritis
CA Wallace et al.
ARTHRITIS AND RHEUMATISM (2005)
Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
V Pascual et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Hydroxychloroquine does not decrease serum methotrexate concentrations in children with juvenile idiopathic arthritis
J Haapasaari et al.
ARTHRITIS AND RHEUMATISM (2005)
Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study
TJA Lehman et al.
JOURNAL OF PEDIATRICS (2004)
Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial
F Zulian et al.
RHEUMATOLOGY (2004)
Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis
F Zulian et al.
RHEUMATOLOGY (2003)
Outcome in adults with juvenile idiopathic arthritis - A quality of life study
HE Foster et al.
ARTHRITIS AND RHEUMATISM (2003)
The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis
MJ Al-Matar et al.
ARTHRITIS AND RHEUMATISM (2002)
Effect of methotrexate on the temporomandibular joint and facial morphology in juvenile rheumatoid arthritis patients
DO Ince et al.
AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS (2000)
Etanercept in children with polyarticular juvenile rheumatoid arthritis.
DJ Lovell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Juvenile chronic arthritis into adulthood: a long-term follow-up study
M Zak et al.
RHEUMATOLOGY (2000)
分享论文
